Regulations.gov document
Guidance for Industry Patient Counseling Information Section of Labeling for Human…
Other · FDA-2013-D-1067 · posted Dec 11, 2014
Key facts
| Document ID | FDA-2013-D-1067-0005 |
|---|---|
| Title | Guidance for Industry Patient Counseling Information Section of Labeling for Human Prescription Drug and Biological Products-Content and Format |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2013-D-1067 |
| Posted | Dec 11, 2014 |
| Comment period opens | Dec 11, 2014 |
| Comments due | Dec 11, 2014 |
At a glance
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: